1.Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease.
Moon Young KIM ; Soon Koo BAIK
The Korean Journal of Hepatology 2008;14(1):1-3
No abstract available.
Carotid Arteries/pathology/ultrasonography
;
Carotid Artery Diseases/diagnosis/*etiology
;
Diabetes Mellitus, Type 2/complications/diagnosis
;
Fatty Liver/*complications/diagnosis/ultrasonography
;
Humans
;
Metabolic Syndrome X/complications/diagnosis
;
Obesity/complications/diagnosis
;
Risk Factors
2.The Relationship between Thyroid Function and the Risk Factors of Cardiovascular Disease at Female Medical Checkups.
The Korean Journal of Laboratory Medicine 2009;29(4):286-292
BACKGROUND: Thyroid hormones play an important role in regulating lipid and glucose metabolism. Thus this study was conducted to investigate the relationship between the thyroid hormone (FT4) or thyroid stimulating hormone (TSH) and the cardiovascular risk factors and metabolic syndrome in the individuals with subclinical thyroid dysfunction. METHODS: The female health examinee with normal range of FT4 were classified into three groups according to the level of TSH; euthyroid group (n=4,410), subclinical hypothyroidism group (n=438) and subclinical hyperthyroidism group (n=66). Age, blood pressure, BMI, fasting glucose, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, lipoprotein(a), and high-sensitivity C-reactive protein (hsCRP) levels of serum specimens were compared among the groups and association of FT4 or TSH with these parameters. RESULTS: Fasting glucose was significantly higher in subclinical hyperthyroidism than in euthyroid and subclinical hypothyroidism groups (P=0.031), and total cholesterol was higher in subclinical hypothyroidism than in subclinical hyperthyroidism (P=0.011). But the other factors showed no difference among the groups. The level of TSH increased as triglyceride increased, while FT4 decreased as BMI or triglyceride increased. The FT4 also lowered when fasting glucose was above 126 mg/dL. TSH was not related with the metabolic syndrome, but the possibility of the syndrome was 1.3 times higher in the lowest quartile of the normal range of FT4 than in its highest quartile. CONCLUSIONS: For the interpretation of FT4, its reference interval needs to be divided into 4 quartiles, which can be used as one of the predicting factors of the metabolic syndrome.
Adult
;
Aged
;
Blood Glucose/analysis
;
Cardiovascular Diseases/*diagnosis
;
Cholesterol/blood
;
Female
;
Humans
;
Hyperthyroidism/complications/diagnosis
;
Metabolic Syndrome X/diagnosis/etiology
;
Middle Aged
;
Odds Ratio
;
Risk Factors
;
Thyroid Gland/*physiology
;
Thyroid Hormones/blood
;
Thyrotropin/blood
3.Clinical Characteristics of Health Screen Examinees with Nonalcoholic Fatty Liver and Normal Liver Function Test.
So Young LEE ; Soo Kyung KIM ; Chang Il KWON ; Moon Jong KIM ; Myung Seo KANG ; Kwang Hyun KO ; Sung Pyo HONG ; Seong Gyu HWANG ; Pil Won PARK ; Kyu Sung RIM
The Korean Journal of Gastroenterology 2008;52(3):161-170
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is known to be closely associated with various metabolic abnormalities including metabolic syndrome. However, there are few data available on the association of metabolic syndrome with the sonographically fatty liver and normal range of liver function test. The purposes of this study were to find the incidence of ultrasonographic fatty liver with normal range of liver function test and to evaluate the association with metabolic syndrome in apparently healthy Korean adults. METHODS: We examined 538 men and women, aged 30-80 years, who participated in a health screening test. Among the people with normal ALT level, we compared clinical characteristics and prevalence of metabolic disorders according to the presence of nonalcoholic sonographyally fatty liver, and then they were subdivided into upper normal range and lower normal range of ALT level. RESULTS: Compared to the people without sonographic fatty liver, people with sonographic fatty liver and normal range of ALT level had odds ratios for metabolic syndrome of 4.53, insulin resistance 4.83, hypertension 2.69, dyslipidemia 6.90, and obesity 5.39, respectively. Furthermore, the prevalence of metabolic syndromes and other metabolic disorders were increased in both sonographically fatty liver group or ultrasonographically normal liver group with upper normal range of ALT level compared with lower normal ALT level (p<0.01). CONCLUSIONS: The nonalcoholic sonographically fatty liver was strongly associated with metabolic syndrome and common metabolic abnormalities even with normal liver function test.
Adult
;
Aged
;
Aged, 80 and over
;
Alanine Transaminase/analysis
;
Chi-Square Distribution
;
Fatty Liver/complications/diagnosis/*ultrasonography
;
Female
;
Humans
;
Insulin Resistance
;
Liver Function Tests
;
Male
;
Metabolic Syndrome X/*diagnosis/epidemiology/etiology
;
Middle Aged
;
Odds Ratio
;
Questionnaires
;
ROC Curve
;
Risk Factors
4.The Prevalence and Clinical Characteristics of Reflux Esophagitis in Koreans and Its Possible Relation to Metabolic Syndrome.
Hyun Joo SONG ; Ki Nam SHIM ; Su Jin YOON ; Seong Eun KIM ; Hee Jung OH ; Kum Hei RYU ; Chang Yoon HA ; Hye Jung YEOM ; Ji Hyun SONG ; Sung Ae JUNG ; Kwon YOO
Journal of Korean Medical Science 2009;24(2):197-202
The prevalence of reflux esophagitis is increasing in Korea. To estimate the prevalence and clinical characteristics of reflux esophagitis in healthy subjects, we retrospectively examined the medical records of healthy subjects undergoing a routine check-up from October 2004 to September 2005. A total of 6,082 (3,590 men, mean age 44+/-10 yr) subjects were enrolled in this study. The prevalence of reflux esophagitis in healthy subjects was 10.5%. According to the univariate analysis, male sex (odds ratio [OR] 3.49, 95% confidence interval [CI] 2.84-4.30), smoking history (OR 1.91, 95% CI 1.60-2.28), body mass index (BMI) >30 kg/m2 (OR 2.13, 95% CI 1.37-3.33), total cholesterol >250 mg/dL (OR 1.50, 95% CI 1.05-2.14), low-density lipoprotein (LDL) cholesterol > or =160 mg/dL (OR 1.52, 95% CI 1.08-2.14), triglyceride > or =150 mg/dL (OR 1.92, 95% CI 1.61-2.30), high blood pressure (BP) (OR 1.46, 95% CI 1.20-1.76), and fasting glucose > or =110 mg/dL (OR 1.45, 95% CI 1.13-1.86) were significantly associated with reflux esophagitis (all p<0.05). However, age, alcohol drinking and Helicobacter pylori infection were not associated with reflux esophagitis. In conclusiosn, significant relationships of reflux esophagitis with obesity, low high-density lipoprotein (HDL) cholesterol, high triglyceride, high BP, and elevated fasting glucose suggested that reflux esophagitis might represent the disease spectrum of the metabolic syndrome.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Data Interpretation, Statistical
;
Esophagitis, Peptic/*diagnosis/*epidemiology/etiology
;
Female
;
Humans
;
Korea/epidemiology
;
Male
;
Medical Records
;
Metabolic Syndrome X/*complications/diagnosis
;
Middle Aged
;
Odds Ratio
;
Prevalence
;
Retrospective Studies
;
Risk Factors
5.Low-Grade Inflammation, Metabolic Syndrome and the Risk of Chronic Kidney Disease: the 2005 Korean National Health and Nutrition Examination Survey.
Hee Taik KANG ; Jong Koo KIM ; Jae Yong SHIM ; Hye Ree LEE ; John A LINTON ; Yong Jae LEE
Journal of Korean Medical Science 2012;27(6):630-635
Either chronic inflammation or metabolic syndrome (MetS) is associated with renal impairment. This cross-sectional study was designed to investigate the relationship between elevated white blood cell (WBC) counts and chronic kidney disease (CKD) stage 3 or more according to the presence of MetS in adult Koreans. In total, 5,291 subjects (> or = 20 yr-old) participating in the 2005 Korean National Health and Nutrition Examination were included. CKD stage 3 or more was defined as having an estimated glomerular filtration rate below 60 mL/min/1.73 m2, as calculated using the formula from the Modification of Diet in Renal Disease study. The odds ratio (95% confidence interval) for CKD stage 3 or more in the highest WBC quartile (> or = 7,200 cells/microL) was 1.70 (1.17-2.39) after adjusting for MetS and other covariates, compared with the lowest WBC quartile (< 5,100 cells/microL). In subjects with MetS, the prevalence risk for CKD stage 3 or more in the highest WBC quartile was 2.25 (1.28-3.95) even after fully adjusting for confounding variables. In contrast, this positive association between WBC quartile and CKD stage 3 or more disappeared in subjects without MetS. Low-grade inflammation is significantly associated with CKD stage 3 or more in subjects with MetS but not in those without MetS.
Adult
;
Cross-Sectional Studies
;
Female
;
Glomerular Filtration Rate
;
Humans
;
Inflammation/complications/*diagnosis
;
Kidney Failure, Chronic/*epidemiology/etiology
;
Leukocyte Count
;
Male
;
Metabolic Syndrome X/complications/*diagnosis
;
Middle Aged
;
Nutrition Surveys
;
Odds Ratio
;
Prevalence
;
Republic of Korea/epidemiology
;
Risk Factors
;
Severity of Illness Index
6.Association between Metabolic Syndrome and Gallbladder Polyps in Healthy Korean Adults.
Eun Jung PARK ; Hong Soo LEE ; Sang Hwa LEE ; Hye Jin CHUN ; Sun Young KIM ; Yu Kyung CHOI ; Hee Jeong RYU ; Kyung Won SHIM
Journal of Korean Medical Science 2013;28(6):876-880
The goal of this study was to evaluate the association between gallbladder (GB) polyps and metabolic syndrome. A total of 5,685 healthy subjects were included, and 485 of these subjects had GB polyps and 744 had metabolic syndrome. In this study, metabolic syndrome was diagnosed according to standards suggested by the AHA/NHLBI ATP III 2005, and abdominal obesity (> or = 90 cm in men and > or = 85 cm in women for Korean) was diagnosed according to standards set forth by the Korean Society for Study of Obesity. Biphasic logistic regression adjusted for age and gender was used to evaluate the association between metabolic syndrome and GB polyps. Subjects who were male (OR, 1.493; 95% CI, 1.11-2.00) and hepatitis B suface Ag (HBsAg) positive (OR, 1.591; 95% CI, 1.06-2.38) were significantly more likely to have GB polyps. The metabolic syndrome group had a higher risk of GB polyps (OR, 1.315; 95% CI, 1.01-1.69) than the group without metabolic syndrome. In conclusion, subjects who were HBsAg positive and male appear to be associated with the risk of GB polyps. The presence of metabolic syndrome also appears to be associated with the risk of GB polyps in Koreans.
Adult
;
Age Factors
;
Asian Continental Ancestry Group
;
Female
;
Gallbladder Diseases/*diagnosis/etiology
;
Hepatitis B Surface Antigens/blood
;
Humans
;
Logistic Models
;
Male
;
Metabolic Syndrome X/complications/*diagnosis
;
Middle Aged
;
Odds Ratio
;
Republic of Korea
;
Risk Factors
;
Severity of Illness Index
;
Sex Factors
7.Heart Rate Variability and Metabolic Syndrome in Hospitalized Patients with Schizophrenia.
Kyunghee LEE ; Jeongeon PARK ; Jeongim CHOI ; Chang Gi PARK
Journal of Korean Academy of Nursing 2011;41(6):788-794
PURPOSE: Reduced heart rate variability significantly increases cardiovascular mortality. Metabolic syndrome increases the cardiac autonomic dysfunction. Recently, increasing cardiovascular mortality has been reported in patients with schizophrenia. This study was done to compare heart rate variability between adults with and without schizophrenia and to compare the relationship of heart rate variability to metabolic syndrome in hospitalized patients with schizophrenia. METHODS: This was a descriptive and correlational study in which 719 adults without schizophrenia and 308 adults with schizophrenia took part between May and June 2008. We measured the following: five-minute heart rate variability; high-frequency, low-frequency, the ratio of low-frequency to high-frequency, and the Standard Deviation of all the normal RR intervals. Data was also collected on metabolic syndrome, abdominal obesity, triglycerides, HDL cholesterol, blood pressure and fasting glucose. RESULTS: The Standard Deviation of all the normal RR intervals values of heart rate variability indices were 1.53+/-0.18. The low-frequency and high-frequency values of heart rate variability indices were significantly higher in hospitalized patients with schizophrenia (3.89+/-1.36; 3.80+/-1.20) than those in the healthy participants (2.20+/-0.46; 2.10+/-0.46). There were no significant differences between the schizophrenic patients with and without metabolic syndrome. CONCLUSION: The results of this study indicate that schizophrenia patients have significantly lower cardiac autonomic control, but they have significantly higher low-frequency and high-frequency values than those of healthy adults. Use of antipsychotic drug may affect the autonomic nervous system in schizophrenic patients. Metabolic syndrome was not associated with cardiac autonomic control in schizophrenia patients.
Adult
;
Autonomic Nervous System/physiopathology
;
Blood Glucose/analysis
;
Blood Pressure
;
Cardiovascular Diseases/complications/diagnosis/mortality
;
Cholesterol, HDL/blood
;
Female
;
*Heart Rate
;
Hospitalization
;
Humans
;
Male
;
Metabolic Syndrome X/*complications/*physiopathology
;
Middle Aged
;
Obesity/etiology
;
Schizophrenia/*complications/mortality/*physiopathology
;
Triglycerides/blood
8.Comparison of Predictability of Cardiovascular Events between Each Metabolic Component in Patients with Metabolic Syndrome Based on the Revised National Cholesterol Education Program Criteria.
In Cheol HWANG ; Kyoung Kon KIM ; Sun Ha JEE ; Hee Cheol KANG
Yonsei Medical Journal 2011;52(2):220-226
PURPOSE: The prevalence of metabolic syndrome (MetS) generally varies depending on its diagnostic definition, and many different definitions inevitably lead to substantial confusion and lack of comparability between studies. Despite extensive research, there is still no gold standard for the definition of MetS, which continues to be a matter of debate. In this study, we investigate whether and to what extent its individual components are related to the risk of cardiovascular disease (CVD) in Korean population. MATERIALS AND METHODS: We used data from the 2005 Korea National Health and Nutrition Examination Survey, which is a nationally representative survey of the noninstitutionalized civilian population. The study sample consisted of 1,406 Korean adults (587 men, 819 women) who were diagnosed with MetS based on the revised National Cholesterol Education Program (NCEP) criteria. Central obesity is defined as a waist circumference cutoff point reported in Asia-Pacific criteria for obesity based on waist circumference by the World Health Organization. CVD was defined as presence of stroke, myocardial infarction, or angina pectoris on a medical history questionnaire. RESULTS: The CVD prevalence among the subjects was 6.8% for men and 8.6% for women. Besides age, the components of MetS showing a significant difference in the number of CVD events were high fasting glucose (FG) in men and high blood pressure (BP) and high FG in women. After adjusting for gender and age, high FG was shown to yield a significant difference (odds ratio: unadjusted 2.08, adjusted 1.81), alone among all MetS components. However, after adjusting for only age, no significant difference was found. CONCLUSION: Fasting glucose level is the highest predicting factor for CVD in Korean patients with MetS based on the revised NECP definition.
Age Factors
;
Blood Glucose/analysis
;
Cardiovascular Diseases/epidemiology/*etiology
;
Chi-Square Distribution
;
Female
;
Health Promotion
;
Health Surveys
;
Humans
;
Hypertension/complications/epidemiology
;
Male
;
Metabolic Syndrome X/complications/*diagnosis/epidemiology
;
Middle Aged
;
Odds Ratio
;
Republic of Korea/epidemiology
;
Risk Factors
;
Sex Factors
9.Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy.
Hyo Jin KIM ; Jee Eun KIM ; Ji Hye JUNG ; Eun Ran KIM ; Sung Noh HONG ; Dong Kyung CHANG ; Hee Jung SON ; Poong Lyul RHEE ; Jae J KIM ; Young Ho KIM
The Korean Journal of Gastroenterology 2015;66(4):202-208
BACKGROUND/AIMS: An association between serum uric acid and cancer risk has been noted over the past few decades. There is ongoing debate about whether hyperuricemia represents an independent risk factor for colorectal neoplasm. We investigated the association between serum uric acid and prevalence of colorectal adenoma considering numerous confounding factors. METHODS: A cross-sectional study was performed with individuals who underwent a routine health check-up examination, including a screening colonoscopy and blood chemistry. The association between serum uric acid and prevalence of colorectal adenoma was estimated from the results of a logistic regression analysis. RESULTS: Of the 1,066 participants, 402 had colorectal adenoma (37.7%). In univariate models, the prevalence of colorectal adenoma was higher in participants in the fourth quartile uric acid level, compared to those in the first quartile uric acid level (OR, 1.67; 95% CI, 1.17-2.42; p=0.004). However, no significant association was detected between serum uric acid and prevalence of colorectal adenoma in multiple logistic regression analysis. A number of metabolic syndrome components exhibited a strong association with the prevalence of colorectal adenoma in the multivariate model (OR, 3.46 for highest vs. lowest; 95% CI, 1.30-9.20; p=0.021). Moreover, serum uric acid was strongly associated with metabolic syndrome-associated variables, including waist circumference, fasting blood glucose, systolic blood pressure, diastolic blood pressure, triglyceride, and high-density lipoprotein. CONCLUSIONS: Uric acid is not an independent risk factor for colorectal adenoma but is a risk indicator for metabolic syndrome-related colorectal adenoma.
Adenoma/*diagnosis/epidemiology/etiology
;
Adult
;
Asian Continental Ancestry Group
;
Blood Glucose/analysis
;
Blood Pressure
;
Colonoscopy
;
Colorectal Neoplasms/*diagnosis/epidemiology/etiology
;
Cross-Sectional Studies
;
Female
;
Humans
;
Logistic Models
;
Male
;
Metabolic Syndrome X/*diagnosis
;
Middle Aged
;
Odds Ratio
;
Prevalence
;
Republic of Korea
;
Risk Factors
;
Triglycerides/blood
;
Uric Acid/*blood/urine
;
Waist Circumference
10.Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma.
Min Young RIM ; Oh Sang KWON ; Minsu HA ; Ju Seung KIM ; Kwang Il KO ; Dong Kyu KIM ; Pil Kyu JANG ; Jung Yoon HAN ; Pyung Hwa PARK ; Young Kul JUNG ; Duck Joo CHOI ; Yun Soo KIM ; Ju Hyun KIM
The Korean Journal of Gastroenterology 2014;63(5):292-298
BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD. METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups. RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70+/-11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56+/-7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37% vs. 17%, p=0.015), hypertension (49% vs. 27%, p=0.051), metabolic syndrome (37% vs. 16%, p=0.001), and higher BMI (25.3 kg/m2 vs. 24.1 kg/m2, p=0.042) than those in the HBV-HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60% vs. 37%, p=0.007). CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.
Age Factors
;
Aged
;
Body Mass Index
;
Carcinoma, Hepatocellular/*diagnosis/etiology/pathology
;
Diabetes Complications
;
Diabetes Mellitus/pathology
;
Female
;
Hepatitis B/complications
;
Humans
;
Hypertension/complications
;
Lipids/blood
;
Liver Neoplasms/*diagnosis/etiology/pathology
;
Male
;
Metabolic Syndrome X/complications
;
Middle Aged
;
Neoplasm Staging
;
Non-alcoholic Fatty Liver Disease/*diagnosis/pathology
;
Risk Factors
;
Severity of Illness Index
;
Sex Factors